Len Yaffee, Kessef Capital, join ‘Fast Money’ to talk Amgen’s obesity drug, Eli Lilly’s current stock action, and much more.
source
Monday, August 31, 2026
Hard for Eli Lilly to move significantly higher from here in the short-term: Kessef Capital’s Yaffee
Leave a Reply
- Trending
- Comments
- Latest
Stay updated with DeFi Daily, your trusted source for the latest news, insights, and analysis in finance and cryptocurrency. Explore breaking news, expert analysis, market data, and educational resources to navigate the world of decentralized finance.